Two family physicians, one UNLOKall Journal Club, and a primary care framework for obesity in later life that starts with strength, not the scale.
More older adults are living with obesity, often alongside multimorbidity and functional decline, yet clear practical guidance is still scarce. In the first UNLOKall Journal Club of 2026, Dr. Gabriel Cuatrecasas, a Barcelona-based family physician with a special interest in obesity, argued that managing obesity in older adults means looking well beyond the number on the scale.
Moderator Dr. Ana Cebrián Cuenca, a family physician in Cartagena, Spain, set out the stakes from the start: in later life, what really matters is function, muscle mass, strength, metabolic health and quality of life, not weight alone.
Dr. Cuatrecasas described a "double burden": a population that grows older every decade, and health systems not yet adapted to treat obesity as a disease in its own right. He also pointed to a gap inside the consulting room itself: older patients are more interested in discussing their weight than physicians are in raising it.
Sarcopenic Obesity: The Condition the Scale Can't See
From a certain age, Dr. Cuatrecasas explained, fat effectively migrates from subcutaneous depots to visceral and ectopic ones, a shift he linked closely to rising cardiometabolic risk. He attributed it largely to hormonal changes after 60 to 65, including in oestrogen and testosterone.
In parallel, muscle mass quietly declines. That, he said, is the silent part of sarcopenic obesity: it cannot be diagnosed in a quick face-to-face consultation, nor by putting the patient on the scale. An older adult can have an apparently normal weight and still be living with it.
He also separated two faces of excess fat: fat mass, which drives mechanical and musculoskeletal problems, and "sick fat", which drives metabolic ones. When muscle loss, bone loss and fat gain occur together, he warned, their effects amplify one another. And while intentional weight loss can be pursued safely, unintentional weight loss may mask cancer, depression or dementia and needs investigating.
Assessing Obesity in Older Adults Beyond BMI
Dr. Cuatrecasas called the widespread reliance on body mass index (BMI) the first failure in assessment, because it cannot distinguish muscle, bone and fat. In its place, he proposed a three-domain assessment that primary care can deliver with very little equipment.
A primary care assessment beyond the scale
BMI aloneAnthropometric
Waist-to-height ratio
Proposed as the new standard for primary care because it tracks visceral fat; some use a threshold of 0.6.
Functional
Handgrip strength (dynamometer): risk below
Sit-to-stand test
Both linked to cardiometabolic disease, hospitalisation and mortality.
Psychological
- Person-first, non-stigmatising language
- Address internalised weight bias
- Review mental health conditions and medications
Source: Dr. Gabriel Cuatrecasas, UNLOKall Journal Club. Cut-offs vary between sources; these are the general values he presented.
For body composition, he noted that bioelectrical impedance analysis (BIA) offers validated cut-offs but is costly and not yet widely available, while ultrasound is promising but still lacks validated thresholds. The functional tests above, by contrast, need little more than a dynamometer and a chair.
The psychological domain, he stressed, is "last but not least". Stigmatising language can shut down engagement, so he recommended speaking of "a person living with obesity" and helping patients understand that their condition is not solely in their hands and warrants medical support.
Eat Enough, Train Against Resistance
Nutrition, according to Dr. Cuatrecasas, is the non-negotiable first step, but it looks different in later life. Older adults experience anabolic resistance and feel full sooner, so the familiar advice to "eat less" can backfire. He advised reinforcing protein intake to stimulate muscle synthesis, with supplements where needed, and checking vitamin D and calcium when bone is also being lost.
Exercise, likewise, has to go beyond walking. He described four complementary types: resistance training, which he called the best way to preserve muscle mass, plus aerobic, balance and flexibility work. Even gentle resistance exercise counts, he said, and primary care is often the only setting where these patients will hear that message.
Where GLP-1 Receptor Agonists Fit
Glucagon-like peptide-1 (GLP-1) receptor agonists have become the most widely prescribed anti-obesity medications of the past five years, but Dr. Cuatrecasas acknowledged that evidence in older people remains limited. Older adults are more sensitive to gastrointestinal effects, already tend to eat less, and frequently live with polypharmacy, including insulin, antidepressants and glucocorticoids.
One early signal on muscle comes from the SEMALEAN study, which he described as a well-conducted prospective study of more than 100 patients treated with semaglutide for a year.
SEMALEAN study
Sarcopenic obesity fell after a year of semaglutide
Prevalence of sarcopenic obesity in more than 100 patients. Mean age was 52, so this is not an older-adult cohort. Source: Dr. Gabriel Cuatrecasas, UNLOKall Journal Club.
Dr. Cuatrecasas was careful to frame this as an interesting pathophysiological first step rather than proof for older patients. He then walked through a recently proposed algorithm that places medication second, not first.
Proposed stepwise approach
Before reaching for anti-obesity medication
-
1
Review polypharmacy
Reduce or stop drugs that work against weight management where possible.
-
2
Protein plus resistance training
1.0 to 1.2 g of protein per kg per day, roughly 80 to 90 g, alongside strength work.
-
3
Continue lifestyle intervention
Nutrition, exercise and behavioural support, sustained over time.
Checkpoint: more than 5% weight loss?
Yes
Keep going with the lifestyle programme.
No
Consider anti-obesity medication, possibly at lower doses, with close follow-up.
Source: algorithm presented by Dr. Gabriel Cuatrecasas, UNLOKall Journal Club.
Health Goals, Not Weight Goals
Both speakers came back to shared decision-making. Dr. Cuatrecasas encouraged clinicians to steer patients away from targets such as losing 10 or 15 kilos and towards goals like playing with their children or climbing stairs more easily. Medication, he said, is not mainly about weight loss: the more important benefits are metabolic and functional.
Dr. Cebrián Cuenca described agreeing realistic goals with each patient and explaining in advance which side effects to expect, how to manage them and when to get in touch. Dr. Cuatrecasas added that engagement starts with listening: a first visit of at least 30 minutes, an atmosphere of trust, and gradual, positively framed steps, supported by bridges to gyms, food stores and the wider community.
Key Takeaways
- A number on the scale Strength, independence and quality of life In later life, treatment goals should centre on what patients can do, not what they weigh. Dr. Ana Cebrián Cuenca and Dr. Gabriel Cuatrecasas
- BMI alone Waist-to-height ratio plus functional tests Excess fat can hide muscle loss, so measure grip strength and chair stands too. Dr. Gabriel Cuatrecasas
- "Eat less" Eat enough, with protein first Anabolic resistance and low appetite make protein intake a priority. Dr. Gabriel Cuatrecasas
- Just walking Resistance, aerobic, balance and flexibility Resistance training is the best way to preserve muscle mass. Dr. Gabriel Cuatrecasas
- Starting with a new drug Reviewing the drug list first Address polypharmacy and lifestyle before adding anti-obesity medication. Dr. Gabriel Cuatrecasas
As Dr. Cebrián Cuenca summarised at the close, sarcopenic obesity is common, silent and harmful. With populations ageing and anti-obesity medications becoming routine, the session makes a strong case for primary care to measure what truly matters to older patients: their muscle, their function and the goals they set for themselves.
Watch the Full Session and Earn 1 CME Credit
This blog only covers the headline ideas. The full recording includes a second, MRI-based study on muscle quality, the obesity paradox in older adults, and a live Q&A on whether AI can support motivation, managing GLP-1 side effects and contraindications, the most practical sarcopenia test for patients on GLP-1 receptor agonists in a busy clinic, predicting who will struggle with side effects, and whether medication is really the best tool available. Register free on UNLOKall to watch the full Journal Club and claim 1 CME credit.
Journal Club: Metabolic Care, Addressing Gaps in Weight Management and Health Support
Watch the SessionMeet the Experts
Dr. Gabriel Cuatrecasas
Family physician based in Barcelona, Spain, with a special interest in obesity and deep involvement in metabolic care.
Dr. Ana Cebrián Cuenca
Family physician in Cartagena, Murcia, Spain, working in primary care.
Note: This post was generated by AI based on our Journal Club: Metabolic Care, Addressing Gaps in Weight Management and Health Support session transcript and reviewed by our editorial team. Access the full recording here.